Drug recall

Apheresis Red Blood Cells, Leukocytes Reduced, Irradiated, Washed

FDA recall event 89891 · Class II · Carter BloodCare

Key facts

Event ID 89891
Recall numbers B-0314-2022
Recalling firm Carter BloodCare
Product type Biologics
Products Apheresis Red Blood Cells, Leukocytes Reduced, Irradiated, Washed
Classification Class II
Status Terminated
Voluntary or mandated Voluntary: Firm Initiated
Reason for recall Apheresis Red Blood Cell product, possibly contaminated with air, was distributed.
Initiation date Mar 9, 2022
Report date Apr 13, 2022
Termination date Apr 7, 2022
City Bedford
State TX
Country United States
FEI number 3002603147

At a glance

  • 1–9 Products in this recall
  • 10–99 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls